13F-HR filed by Sofinnova Investments, Inc.
Sofinnova Investments, Inc. filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 66 holding rows worth $1,585,234,552.
- Accession
- 0001104659-23-118095
- Filer
- CIK 1631134
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 69 entries on the cover page, a total value of $1,585,234,552 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,585,234,552 with VALUE read as dollars as filed, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 1,381,149 | $233,538,484 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 3,100,560 | $137,199,780 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 1,362,836 | $92,291,254 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 728,404 | $74,989,192 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 754,032 | $70,607,556 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 2,419,528 | $53,713,522 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 550,197 | $51,333,380 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 3,758,686 | $51,005,369 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 173,277 | $50,647,134 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 3,467,156 | $47,534,709 | dollars as filed | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 3,610,024 | $40,576,670 | dollars as filed | |
| iShares Russell 2000 ETF | 464287655 | SHS | 225,000 | $39,766,500 | dollars as filed | put |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 78,186 | $38,438,583 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 3,251,509 | $37,652,474 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 695,375 | $37,299,915 | dollars as filed | |
| KENVUE INC | 49177J102 | COM | 1,802,084 | $36,185,847 | dollars as filed | |
| IDEXX LABS INC COM | 45168D104 | Stock | 77,881 | $34,055,025 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 2,045,202 | $32,457,356 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,060,164 | $31,232,431 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,037,187 | $27,983,305 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,211,641 | $24,305,518 | dollars as filed | |
| SPY | 78462F103 | SHS | 50,000 | $21,374,000 | dollars as filed | put |
| EXELIXIS INC COM | 30161Q104 | Stock | 912,600 | $19,940,310 | dollars as filed | put |
| EXELIXIS INC COM | 30161Q104 | Stock | 830,764 | $18,152,193 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 4,280,308 | $17,977,294 | dollars as filed | |
| INVESCO QQQ TR | 46090E953 | PUT | 50,000 | $17,913,500 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 292,805 | $16,689,885 | dollars as filed | |
| Shockwave Med Inc | Shockwave | COM | 81,373 | $16,201,364 | dollars as filed | |
| AGENUS INC | 00847G705 | COM NEW | 13,364,748 | $15,102,165 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 537,464 | $15,054,367 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 500,000 | $14,730,000 | dollars as filed | put |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 941,817 | $13,675,183 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 743,294 | $13,639,445 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 2,194,278 | $11,958,815 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 424,259 | $11,675,608 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 202,119 | $10,190,840 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 200,000 | $9,078,000 | dollars as filed | put |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 600,000 | $8,712,000 | dollars as filed | call |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 503,844 | $8,620,771 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 985,606 | $7,934,128 | dollars as filed | |
| GERON CORP | 374163103 | COM | 3,702,546 | $7,849,398 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 450,000 | $6,534,000 | dollars as filed | put |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 51,100 | $6,194,342 | dollars as filed | call |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 685,133 | $6,138,792 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 80,368 | $5,616,920 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 200,000 | $5,504,000 | dollars as filed | put |
| IMMUNOVANT INC | 45258J102 | COM | 139,885 | $5,370,185 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 313,100 | $5,357,141 | dollars as filed | put |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 250,000 | $4,277,500 | dollars as filed | call |
| NEXTCURE INC | 65343E108 | COM | 2,671,856 | $3,446,694 | dollars as filed | |
| NUCANA PLC | 67022C106 | ADR | 5,599,999 | $3,415,999 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 2,754,437 | $2,864,614 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 320,600 | $2,580,830 | dollars as filed | call |
| AGENUS INC | 00847G705 | COM NEW | 1,600,000 | $1,808,000 | dollars as filed | call |
| Nucana PLC | GB00BYWYV | COMMON SHARES | 2,400,000 | $1,464,000 | dollars as filed | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 318,896 | $1,128,892 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 3,279 | $896,052 | dollars as filed | |
| PDS BIOTECHNOLOGY CORP | 70465T107 | COM | 142,635 | $720,307 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 157,908 | $596,892 | dollars as filed | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 3,083,712 | $539,958 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 115,712 | $501,033 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 117,099 | $304,457 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 9,089 | $287,212 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 11,040 | $164,606 | dollars as filed | put |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 58,029 | $131,146 | dollars as filed | |
| SYNLOGIC INC | 87166L209 | COM | 38,331 | $107,710 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-118095 | this filing | 2023-11-14 | acceptance time not in the bulk data set |